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Background: The experience sampling method (ESM) builds an intensive time series of experi-
ences and contexts in the flow of daily life, typically consisting of around 70 reports, collected at
8–10 random time points per day over a period of up to 10 days.
Methods: With the advent of widespread smartphone use, ESM can be used in routine clinical
practice. Multiple examples of ESM data collections across different patient groups and settings
are shown and discussed, varying from an ESM evaluation of a 6-week randomized trial of mind-
fulness, to a twin study on emotion dynamics in daily life.
Results:Research shows that ESM-based self-monitoring and feedback can enhance resilience by
strengthening the capacity to use natural rewards. Personalized trajectories of starting or stop-
ping medication can be more easily initiated and predicted if sensitive feedback data are avail-
able in real time. In addition, personalized trajectories of symptoms, cognitive abilities, symptoms
impacting on other symptoms, the capacity of the dynamic system of mental health to “bounce
back” from disturbance, and patterns of environmental reactivity yield uniquely personal data to
support shared decision making and prediction in clinical practice. Finally, ESM makes it possible
to develop insight into previous implicit patterns of thought, experience, andbehavior, particularly
if rapid personalized feedback is available.
Conclusions: ESM enhances clinical practice and research. It is empowering, providing co-
ownership of the process of diagnosis, treatment evaluation, and routine outcomemeasurement.
Blended care, based on a mix of face-to-face and ESM-based outside-the-office treatment, may
reduce costs and improve outcomes.
K EYWORDS
depression, ecological momentary assessment, patient-reported outcome, self-assessment, self-
care
1 INTRODUCTION
The practice of mental health is changing rapidly, requiring new tools
to involve patients in the process of diagnosis and treatment, and to
provide perspectives of acceptance and sense of purpose. Two factors
are particularly important. First, treatment models propose a more
active and empowered role of patients, with active self-management
and shared decision making as core elements (Huber et al., 2011).
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Self-monitoring is a main component of self-management, providing
an opportunity for collaborative diagnosis and treatment evaluation,
and forming the starting point for self-insight and initiation of change
in patterns of experience and behavior. Second, the process of assess-
ment and treatment in mental health care is becoming more personal-
ized. Traditional diagnostic and guideline-based practice for the “aver-
age” patient is being complemented with more dynamic, personalized
formulations of psychopathology as a within-person series of mental
states that evolve over time, under the influence of daily life environ-
ments and the impact of mental states on each other, requiring per-
sonalized solutions. The fit of selected intervention strategies can be
assessed, and personalized formulations reevaluated in an iterative
monitoring process toward shared decisionmaking.
In this article, we will discuss how the collection of intensive con-
textual mental state data, known as the experience sampling method
(ESM) or ecological momentary assessment (EMA; Csikszentmihalyi,
Larson, &Prescott, 1977), in the formof anmHealth smartphone appli-
cation, has the potential to become a mainstream instrument to sup-
port self-monitoring, personalized health care and the development of
self-insight and avenues for personal change and acceptance of disabil-
ities in clinical practice. Although ESM was initially used as a research
tool in social psychology and the study of psychopathology, it was
also found to have value in the management of (severe) mental illness
(aan het Rot, Hogenelst, & Schoevers, 2012; Delespaul, 1995; Ebner-
Priemer & Trull, 2009;Myin-Germeys et al., 2009; Palmier-Claus et al.,
2012;Walz, Nauta, & aan het Rot, 2014). Smartphones and customized
apps have dramatically simplified the user experience and reduced the
logistic burden of data collection and analysis. ESM is now available as
a free mHealth smartphone app in Apple App Store and Android Store
(e.g., PsyMate, xSample,movisensXS,BeepMe,RealLife). Free availabil-
ity makes it possible to use ESM in regular clinical practice. Although
themultilevel analysis of ESM research data can be complex, even sim-
ple graphical feedback of ESM data can represent a source of substan-
tial enrichmentof clinical practice. Bymakinguseof thedata at theper-
sonal and the descriptive level, testing n = 1 clinical hypotheses about
diagnosis, treatment, change, and acceptance becomes possible (Bak,
Drukker, Hasmi, & vanOs, 2016; Delespaul, 1995).
2 THE PRACTICE OF ESM
ESM is a structured data collection technique in which participants
respond to randomly timed repeated assessments (up to around 10
times per day) over the course of time (up to around 10 days—with
extensions of up to 1 year) while functioning within their natural
setting (Csikszentmihalyi et al., 1977; Delespaul, 1995; Fig. 1). The
sampling is signal-contingent, meaning that individuals respond to
semirandom signals (“beeps’”—typically one random beep per 90-min
slot). Data collection focusses on (i) emotions—items that reflect the
broad dimensions of positive affect (PA; e.g., cheerful, relaxed, satis-
fied, happy) and negative affect (e.g., down, lonely, anxious, insecure);
(ii) contexts—where, with whom, events; (iii) activities—doing what,
(iv) food, alcohol, drugs, medication; (v) aspects of psychopathology –
psychotic phenomena, suicidality, craving, self-esteem; (vi) somatic
F IGURE 1 Principles of experience sampling methodology (ESM) or
ecological momentary assessment (EMA)
Notes: At 10 random moments during the day, mental states
(e.g., anxiety, low mood, paranoia, being happy) and contexts (stress,
company, activity, drug use) are assessed. The arrows represent
examples of prospectively analyzing the impact of mental states and
contexts on each other over time, allowing for the construction of
composite measures such as stress-sensitivity (impact of stress on
negative affect), reward experience (impact of positive events on
positive affect), or the autocorrelation (the impact of the mental state
on itself from one moment to the other, resulting in more or less
persistence over time).
symptoms (e.g., pain, fatigue, dizziness, tinnitus, etc.); and (vii) stress—
stressful momentary events, stress associated with momentary activ-
ity (e.g., “This activity is difficult for me,” “I would prefer doing some-
thing else”), stress associated with momentary company (e.g., “I find
being with these people pleasant[reversely coded to reflect stress]”).
For use in routine clinical practice, a sampling scheme with eight ran-
dom signals per day and no more than 30 items to rate is generally
feasible (Delespaul, 1995). With adequate software, subjects can rate
responses within 1 min, only minimally disturbing the flow of normal
daily routines.A sampling schemeof less thaneight timesperdayyields
insufficient measurements, given a normally 20–30% beep attrition
in natural circumstances (Delespaul, 1995). Furthermore, care must
be taken to include only items that can vary momentarily (e.g., “I am
angry”) rather than items reflecting trait, that do not varymomentarily
(“I am clever”).
ESM has a number of advantages (Delespaul, 1995). First, it gives
the clinician insight in the contingencies of experience and behav-
ior, based on prospective data. Second, ESM observations have, con-
trary to clinical interactions, ecological validity, reflecting real life vari-
ation in response to real life challenges. Third, ESM makes use of
in-the-moment reports not subject to memory biases and “global eval-
uation” distortions. Fourth, although ESM requires considerable moti-
vation on the part of the patient, this motivation likely correlates with
motivation for change in the context of treatment. Given that this is
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an important clinical variable, ESM can be revealing, to both patient
and attending clinician with respect to motivation for change. Fifth,
ESMallows for a prospective, within-person approach to diagnosis and
treatment, contrasting with the between-person, “average patient”
approach of traditional evidence-based practice. Sixth, evidence indi-
cates that ESM empowers patients to become actively involved in
collecting data, pertinent to treatment and assessment, in their own
environments, thus becoming minimally co-participant (Wichers et al.,
2011) and possibly part-owner of the process of care (Simons et al.,
2015).
Although ESM can be combined with a range of sensor-based data
(movement, position, activity) and ambulatory physiological measures
(e.g., salivary cortisol, heart rate, bloodpressure, voidingbehavior, etc.),
more research is required on their added value to ESM ratings of expe-
rience and behavior. Furthermore, while a range of physiological mea-
sures can be measured in daily life, their relevance for mental health
diagnosis and treatment remains to be established.
3 CLINICAL APPLICATIONS OF ESM
3.1 From group-based data to n= 1 predictions
A local database with a large number of observations pertaining to
different patient groups is helpful as a reference for the interpreta-
tion of clinical ESM data in individual patients. Next, a number of clin-
ical applications of ESM will be illustrated using data from the ESM
database that is being managed at Maastricht University (version 4.6).
The database contains ESM studies that were conducted on different
populations with comparable ESM lists, although not all ESM items
were available in each group. Version 4.6 of the ESMdatabase contains
data on276healthy controls, 601healthy twins from thegeneral popu-
lation, 178 relatives of patients with a psychotic disorder, 293 patients
with psychotic disorder, 115 patients with depression, 129 patients
with residual depression, and 106 individuals with variable levels of
psychometric risk for psychotic disorder. We will show that ESM pat-
terns at the group level are highly informative and form an attractive
basis for testing hypotheses in single patient ESM data.
3.2 Assessing psychopathology variation and
reactivity across time and place
Figures 2 and 3 display the simple variation over time and place of
momentary “feeling low” in controls, individuals with residual depres-
sion, and individuals with depression. The graphs show clear differ-
ences in terms of severity, pattern of variation over time (Fig. 2), and
pattern of reactivity as a function of place (Fig. 3). In controls, themood
item remains constant at low levels, showing little variation as a func-
tion of location. From individuals with residual depression to individ-
uals with depression, “feeling low” is progressively more severe and
showing progressively more diurnal variation. Furthermore, the data
in the depressed groups showmore reactivity as a function of location,
with the greatest severity being associated with health care locations,
as well as during transport.
Although the Figures 2 and 3 thus suggest clear andmeaningful dif-
ferences between groups, the interpretation of individual ESM data
remains a challenge. Figure 4 shows individual trajectories of momen-
tary variation of the mood item “feeling low,” separately for each
patient in the depression group. These individual trajectories show
very substantial variation from beep to beep and day to day, between
and within persons. Such variation nevertheless has a meaningful and
clinically interpretable pattern within individuals, differing from other
persons, and is not entirely random. Therefore, ESM allows for clinical
inspection and interpretation of data at both the group and individual
levels.
3.3 Assessing dynamic system ability to bounce
back from disturbance
An emerging concept in psychopathology is the ability to bounce back
given disturbance and impendingmental decompensation in a dynamic
systemmodel of psychopathology (Odgers et al., 2009;Wichers,Groot,
& ESM-Merge Group, 2016). For example, alterations in mood may
cause a person to perceive the environment as threatening or alien.
Initially, the person may be able to “shake off” this impression of aber-
rant salience, indicating resilience and stability, with a rapid return of
the alteredmental state to baseline in the face of disturbing influences.
However, in more advanced stages, the person may not rapidly return
to the baseline mental state and progressively spend more and more
time in the altered mental state of aberrant salience (Wigman et al.,
2013). ESM data are suitable to capture this process of progressive
loss of flexibility and ability to bounce back given system disturbance
by plotting the autocorrelation of successive mental states. The auto-
correlation of a mental state in ESM is the similarity between obser-
vations as a function of the time lag between them, or the tendency of
the mental state to persist from one moment to the other over time
(Wigman et al., 2013). In Figure 5a, controls have low variability in
the ESM item indexing paranoia, therefore the autocorrelation func-
tion is low and not necessarily informative on the ability to bounce
back from paranoid mental state deviations. In patient groups, ESM
data are less ambiguous in this regard, allowing for interpretation of
the autocorrelation. Thus, those with residual depression have altered
bounce back ability (less rapid return to baseline), whereas individu-
als with psychotic disorder show paranoia inflexibility (Fig. 5a). Fig-
ure 5b shows that from controls to residual depression to depression,
there is a decrease in bounce back ability from mental states devia-
tions characterized by anxiety. However, no such differences are seen
for the item of “difficulty concentrating” (Fig. 5c), suggesting that alter-
ations of mental state flexibility may occur independently across dif-
ferent mental states, and that there may be a “hierarchy” (within and
between persons) in the level of volatility in emotions and experiences,
ranging from extreme volatility to “trait”-like persistence. In addition,
charting the autocorrelation as a function of resilience to “bounce
back” from disturbance may inform on environmental or genetic risk
factors, as shown in Figure 5d, which depicts altered capacity to
bounce back from the mental state of anxiety as a function of parental
divorce. Alterations in the ability to bounce back from disturbance
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F IGURE 2 Momentary, beep-level self-reports (maximumof60beeps) of themeanof theESM item “feeling down,” collectedover 6days, in three
samples of, respectively, controls (N = 251, n = 12,394 beep moments), patients with residual depression (N = 129, n = 6,420 beep moments), and
depression (N= 45, n= 2,287 beepmoments)
F IGURE 3 Self-reports of the ESM item “feeling down,” collected over 6 days in daily life, summarized asmean level per location in three samples
of controls (N= 251, n= 12,394 beepmoments), patients with residual depression (N= 129, n= 6,420 beepmoments), and depression (N= 45, n=
2,287 beepmoments)
can also be studied within individuals, particularly in longer ESM tra-
jectories, as a function of treatment response and prediction of out-
come (Wichers et al., 2016). Conversely, a greater autocorrelation in
PA, that is, a greater level of momentary transfer of positive emotions,
may be protective, as it was associated with a greater recovery rate
and prevention of depressive episodes (Hohn et al., 2013). To date,
however, lengthy ESM-based time series remain rare in the research
literature.
3.4 Assessing the impact of symptoms on each other
The above example provides indirect evidence of how one mental
state (low mood) affects another mental state (paranoia), increas-
ing levels of low mood apparently giving rise to progressively higher
levels of paranoia. However, ESM data also allow for a more direct
examination of this process, bymodeling the prospective relationships
between mental states and symptoms. Given the fact that ESM data
represent a time series, it is possible to examine the impact of, for
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F IGURE 4 Trajectories of momentary (n = 1), beep-level ESM self-
reports of “feeling down,” collected over 6 days, in a sample of
depressed patients (N= 45, n= 2,287 beepmoments)
example, the level of anxiety at the preceding beep (time point t − 1)
on low mood at the next beep (time point t). Similar analyses can be
carried out at other levels of aggregation, for example, at day-level.
These types of analyses have to take into account natural “breaks” in
the data, avoiding, for example, that an ESM item pertaining to the first
beep of one day is predicted by an ESM itempertaining to the last beep
of the previous day. In Figure 6, prospective relationships are assessed
betweenmomentary anxiety anddepression, andbetweenmomentary
feeling happy, on the one hand, and anxiety and depression, on the
other. In those with low momentary levels of depression at t − 1, anx-
iety at t − 1 drives the incidence of depression at t in a dose-response
fashion.Vice versa,momentarydepression at t−1drives incident anxi-
ety at t. The twomental states can thus be said tomutually impact each
other’s momentary incidence in a reinforcing loop. In contrast, feeling
happy at t − 1 protects, in a dose-response fashion, against the onset
of both anxiety and depression (Fig. 6). Dynamic prospective relation-
ships between mental states and symptoms can be extended to a full
network of mutually impacting momentary mental states, involving
multiple symptoms (Borsboom, & Cramer, 2013). Although between-
person analyses are helpful to examine dynamics at the group-level,
ESM allows for examination of within-person relationships and their
impact on treatment. The concept of ESM clinical network analysiswas
recently introduced to describe the possibility of collecting ESM data
for an extended period to help patients gain insight in the dynamics
of the underlying psychopathology to decide which are the best con-
nected points in the network where change likely will affect the most
other symptoms and to assess the impact of treatment in the network
(Bak et al., 2016). For example, Bak et al. (2016) showed the example
of a person with disabling auditory hallucinations that were fuelled by
a mutually reinforcing loop of paranoia and low mood, allowing for a
more focused treatment approach.
3.5 Assessing the impact of the environment
One of the important advantages of ESM is the ability to link momen-
tary measures of experience and behavior to self-reports of the envi-
ronment. In Figure 7a, momentary reports of low mood as a func-
tion of activity stress (the rating of the momentary activity in terms
of “I would rather do something else”) are compared between a con-
trol group and a group with residual depression. The results show that
lowmood in controls has constant low values, not responding much to
increases in activity stress,whereas lowmood in individualswith resid-
ual depression appears to be much more reactive to the stressor. Sim-
ilarly, momentary events rated as more pleasant neutralize momen-
tary low mood in controls to a small degree, whereas a much greater
protective effect is seen in patients with residual depression (Fig. 7b).
This latter finding of greater reductions in negative affect following
positive events is consistent with an independent report in the liter-
ature in patients with depression (Bylsma, Taylor-Clift, & Rottenberg,
2011). The “buffering” effect of positive events is considerable: in Fig-
ure 7b, the level of lowmood in the patient group at the highest level of
pleasant event exposure approaches that of the control group. In other
words, individuals with depression have higher levels of low mood,
and are also more responsive to perceptions of environmental stress
and environmental reward, which is in agreement with findings from
other ESM studies (Audrain-McGovern, Wileyto, Ashare, Cuevas, &
Strasser, 2014;Myin-Germeys et al., 2003; Peeters, Nicolson, Berkhof,
Delespaul, & deVries, 2003). Theorigins of increasedmomentarymood
reactivity in depression have been linked to genetic liability for depres-
sion (Peeters et al., 2003; M. Wichers et al., 2007) as well as to child-
hood trauma (Wichers et al., 2009), suggesting that ESM measures of
reactivity can provide information on the mechanism whereby genes
and environment confer vulnerability and resilience to depression. For
example, one study found that in individuals with genetic liability for
depression, the ability to generate positive emotions in response to
the environment prevented the expression of genetic risk in lowmood
states (Wichers et al., 2007).
3.6 Assessing ecological cognition
Contextual sensitivity is related to the cognitive ability to detect envi-
ronmental changes. Environmental adaptation strategies or optimized
coping assume that subjects are able to detect clues and use these in
a learning process (in which PA and avoidance of stress function as
rewards). There is a need to understand whether the cognitive skills
are influenced by the changing environment, or by the way individu-
als assess these skills in daily life. It is therefore important to under-
stand changes in cognition within the same time frame as changes in
emotions and context. The assessment of variation in cognitive func-
tion in daily life is a challenge. The first reason is that the tests used
in traditional cross-sectional assessments often rely on repeated trials
lasting some minutes. This is difficult to implement in daily life given
the time restraints of ESM—disruption should be restricted to 1–2min
maximally. Second, cognitive tests need contextual standardization to
be reliable. The circumstances of the daily life assessments are highly
variable and make it difficult to fully focus on the test. Third, ESM
measurements are typically replicated 10 times each day for days or
weeks. Such a sampling scheme requires a battery of parallel testswith
limited training effects. More knowledge is required to design tests
that canbeused toassessdifferentdimensionsof cognitive functioning
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in daily life. Currently, pilots are being conducted to test the implemen-
tation of short cognitive tasks in ESM. These pilot studies are related
tomemory (i.e., recall and recognition, both with and without interme-
diate tasks), concentration (i.e., coding tasks or elementary computa-
tions), reasoning (i.e., mathematical problem solving), and planning, in
addition to tests that are related to cognitive biases and social cogni-
tion such as “jumping to conclusions” and “theory of mind.”
3.7 ESM as a tool for positive emotion enhancement
Given ecological validity, low cost, and smartphone availability,
there is increasing interest in using ESM in the context of trials
(Verhagen, Hasmi, Drukker, van Os, & Delespaul, 2016). For exam-
ple, there is evidence that monotherapy with psychotropic medica-
tion may not constitute optimal care for common mental disorders.
Instead, treatment combining medication with some form of behav-
F IGURE 5 (a) Autocorrelations over successive lags of the ESM mental state of feeling “suspicious” (paranoia), collected over 6 days (10 beeps
per day, nine lags), in three samples of controls (N = 212, n = 10,260 beep moments), patients with residual depression (N = 129, n = 6,412 beep
moments) and psychotic disorder (N= 293, n= 12,400 beepmoments). (b) Autocorrelations over successive lags of the ESMmental state of feeling
“anxious,” collected over 6 days (10 beeps per day, nine lags), in three samples of controls (N = 276, n = 13,513 beep moments), patients with
residual depression (N = 129, n = 6,420 beep moments), and depression (N = 114, n = 5,324 beep moments). (c) Autocorrelations over successive
lags of the ESM mental state of “difficulties concentrating,” collected over 6 days (10 beeps per day, nine lags), in three samples of controls (N =
276, n = 13,199 beep moments), patients with residual depression (N = 129, n = 6,483 beep moments), and depression (N = 115, n = 5,329 beep
moments). (d) Autocorrelations over successive lags of the ESMmental state of “feeling anxious,” collected over 5 days (10 beeps per day, nine lags)
in a general population sample of twins of whom N = 525 (n = 18,991 beeps) reported no parental divorce and N = 51 (n = 1,852 beeps) reported
parental divorce
F IGURE 6 Predicting the incidence (i.e.,mean level ofmood state at t in thosewith the lowest score of thatmood state at beep t−1), as a function
of the level of another mood state at beep t − 1, in a sample of individuals with residual depression (N = 223, n = 10,582 beeps). For example, in
those with the lowest score of “feeling down” at t − 1, higher levels of anxiety at t − 1 predict progressively greater levels of feeling down at t, and
higher level of feeling happy at t− 1 predict progressively lower scores of feeling down at t
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F IGURE 7 (a) Mean of self-reported ESM item “feeling down,” collected over 6 days in daily life, summarized over increasing levels of activity-
related stress in a sampleof controls (N=212,n=10,142beepmoments) anda sampleof patientswith residual depression (N=129,n=6,425beep
moments). (b)Mean of self-reported ESM item “feeling down,” collected over 6 days in daily life, summarized over increasing levels of how pleasant
momentary events were rated of in a sample of controls (N= 212, n= 9,777 beepmoments) and a sample of patients with residual depression (N=
129, n= 6,250 beepmoments)
ioral intervention appears more effective than treatment with med-
ication alone (Cuijpers et al., 2014). Given the fact that (i) behav-
ioral interventions, complex or simple, appear to have similar effect
sizes in the treatment of common mental disorder (Cuijpers, Donker,
van Straten, Li, & Andersson, 2010) and (ii) simple mHealth self-
monitoring interventions can add to the treatment ofmental disorders
(Berrouiguet, Baca-Garcia, Brandt, Walter, & Courtet, 2016), there is
interest in the concept of adding self-monitoring interventions tomed-
ication in the treatment of common mental disorder as a strategy to
enhance the effect that would have been obtained with medication
alone. A recent randomized trial added an ESM-based self-monitoring
intervention, combined with feedback on how to improve patterns of
generating PA in daily life, based on ESM self-monitoring data, to
medication in patients treated for depression. This type of feedback
can consist simply of systematically examining instances of positive
emotions in daily life, and discussing strategies to increase the fre-
quency of such moments and/or increase the persistence of pos-
itive emotions in daily life. Patients receiving the combination of
medication and the ESM-based self-monitoring and positive emotion
enhancement tool did better than patients receiving medication alone
(Kramer et al., 2014). These data suggest that ESM self-monitoring
and positive emotion feedback paradigms may be added routinely to
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F IGURE 8 ESMmomentary levels of positive affect (PA—themean of eight momentary positive emotions) in 26 patients with depression during
the first 3 days of imipramine treatment, stratified by responder status (50% reduction in HAMD) at 6 weeks (n= 26, 578 beepmoments)
treatmentwith psychotropicmedication in clinical practice. It has been
suggested that antidepressant medication may work by facilitating
the process of practice-induced plasticity (Sterling, 2014). ESM, as
a context-sensitive tool to help individuals optimizing environmental
interactions and coping (Lardinois et al., 2007), may be well placed to
enhance the practice required for the plasticity-enhancing effect of
antidepressants. Momentary assessment interventions may be used
to enhance nonpharmacological interventions as well. For example,
Depp et al. (2015) showed that adding an ecological momentary inter-
vention targeting self-management of mood symptoms increased the
effect of a brief psychoeducation on depressive symptoms. However,
results also showed that the benefits only lasted as long as the mobile
intervention was ongoing (Depp et al., 2015). Batink et al. (2016)
introduced an ESM-based mHealth paradigm as an add-on interven-
tion to help patients practice with acceptance and commitment ther-
apy (ACT) in their daily lives. The intervention proved practicable
and feasible for patients, with high levels of adherence. Although
no short-term effects could be demonstrated, the authors hypothe-
sized that effects of ACT may take longer to transpire (Batink et al.,
2016).
3.8 ESM as a tool for tapering and dose finding of
psychotropic medication
Symptoms of anxiety, depression, and psychosis are sensitive to a
range of pharmacological interventions. There are considerable chal-
lenges in finding the right dose for a given individual and there is
widespread variation in the level of difficulties patients experience
when coming off psychotropic medications. There is growing aware-
ness that personalized dosing of psychotropic medication has been—
and still is—a neglected area in clinical psychiatry, as is the personal-
ized approach toward reducing or stopping psychotropic medication.
ESM studies have shown that intensive sampling of emotions and con-
text represents a sensitive tool to pick up the early effects of changing
dose and reducing medications (Bak et al., 2016; Barge-Schaapveld &
Nicolson, 2002; Lataster et al., 2011a, 2011b; Wichers et al., 2009),
as well as picking up early changes after dose reduction that may pre-
dict imminent relapse (Wichers et al., 2016). Given the potential of
ESM to empower the patient to cocreate diagnosis and treatment eval-
uation, as well as the observed synergistic effects between ESM as
a self-management tool and psychotropic medication, described ear-
lier, a case could be made for the routine use of ESM when initiat-
ing or reducing psychotropic medication. For example, when starting
antidepressant medication, ESM in the first week can pick up signs of
early response in the form of increases in the ability to use natural
rewards (variation in positive emotions after positive events in daily
life;Wichers et al., 2009); or reduction of antipsychoticmedication can
be monitored with ESM for alterations in subtle experiences of aber-
rant salience as a sign of dopamine supersensitivity syndrome (Murray
et al., 2016).
In Figure 8, we show descriptive ESM data of early response
to an antidepressant in a randomized, placebo-controlled trial of
imipramine in a group of patients with depressive disorder described
previously (Barge-Schaapveld, Nicolson, van der Hoop, & De Vries,
1995; van Os, Delespaul, Barge, & Bakker, 2014; Wichers et al.,
2009). Only participants randomized to the imipramine group with
valid ESM data and outcomes at 6 weeks are shown (n = 26).
Response at 6 weeks was defined as a reduction of 50% or more
in baseline Hamilton Depression Rating Scale (HAMD) score. Fig-
ure 8 shows the ESM momentary levels of PA, stratified by future
responder status, during the first 3 days of imipramine treatment.
Future responders have higher levels of PA (Fig. 8). Thus, ESM tra-
jectories may index information on future response in routine clinical
practice.
VAN OS ET AL. 489
F
IG
U
R
E
9
O
n
lin
e
co
n
te
xt
u
al
fe
ed
b
ac
k
o
n
a
co
m
p
o
si
te
p
o
si
ti
ve
af
fe
ct
va
ri
ab
le
d
er
iv
ed
fr
o
m
m
o
m
en
ta
ry
as
se
ss
m
en
t.
In
th
e
fe
ed
b
ac
k
gr
ap
h
,t
h
e
so
lid
lin
e
in
d
ic
at
es
th
e
m
ea
n
le
ve
lo
f
th
e
co
m
p
o
si
te
va
ri
ab
le
“p
o
si
ti
ve
af
fe
ct
”
(P
A
)
p
er
d
ay
.T
h
e
d
o
tt
ed
lin
e
is
th
e
le
ve
lo
f
PA
if
th
e
le
ve
lo
f
PA
d
u
ri
n
g
m
o
m
en
ts
o
f
“l
ei
su
re
”
(p
ie
ch
ar
t
o
n
th
e
ri
gh
t-
h
an
d
si
d
e)
,a
s
in
d
ic
at
ed
d
u
ri
n
g
th
e
m
o
m
en
ta
ry
as
se
ss
m
en
t
p
er
io
d
,i
s
n
o
t
ta
ke
n
in
to
ac
co
u
n
t—
in
th
is
ca
se
re
su
lt
in
g
in
m
o
st
ly
lo
w
er
le
ve
ls
o
fP
A
490 VAN OS ET AL.
3.9 ESM as a tool for collaborative care in somatic
settings
Experiential and behavioral outcomes are central in the diagnosis and
treatment of a range of stress-related somatic syndromes, ranging
from Alzheimer and Parkinson’s disease to irritable bowel syndrome,
pain, tinnitus, Chronic Obstructive Pulmonary Disease (COPD), dia-
betes, and urinary incontinence. ESM studies show that mood states
and contextual factors interact with specific experiential outcomes in
these disorders, and that ESM can facilitate management and collabo-
rative care approaches in the hospital (Broen et al., 2016; Bruehl, Liu,
Burns, Chont, & Jamison, 2012; Fischer et al., 2016; Leue et al., 2017;
Mujagic et al., 2014, 2015; van Knippenberg et al., 2016; Vrijens et al.,
2015). For example, deep brain stimulation is used in Parkinson’s dis-
ease, however, it is often very difficult to assess subtle experiential,
cognitive, and behavioral side effects associated with this treatment.
A pilot study has shown that ESM can be used to assess both the men-
tal and themotor symptoms in Parkinson’s disease (Broen et al., 2016);
follow-up work is required to assess the effects of deep brain stimu-
lation in this condition. Similarly, the effects of treatment on irritable
bowel syndrome are very difficult to capture using conventional meth-
ods; it has been suggested that ESMmay be used routinely in random-
ized trials in this disorder (Mujagic et al., 2015).
3.10 ESM as a form of routine outcomemonitoring
with a focus on positivemood states
There is consistent evidence that the impact of both pharmacological
and nonpharmacological treatments ismediated by enhancing positive
emotions, more than reduction of negative emotions, although inter-
ventions can be shown to also impact negative emotions and reactiv-
ity to negative events (Silk et al., 2016). In a randomized controlled
trial of antidepressants, improvement in the ability to generate posi-
tive emotions differentiated responders and nonresponders to antide-
pressantsmedication (Wichers et al., 2009). Similarly, in another inves-
tigation, it was shown that early improvement in ESM-based posi-
tive emotions was a better predictor of outcome than improvement
in momentary negative emotions (Geschwind et al., 2011). Trial evi-
dence indicates thatmindfulness training is effective for the treatment
of depression and anxiety (Hofmann, Sawyer,Witt, &Oh, 2010) and for
preventing depression relapse (Kuyken et al., 2015). In a randomized
trial of mindfulness training in depression, the underlying emotional
mechanismwas investigatedwith ESM. The results revealed that, simi-
lar to antidepressant medication, clinical improvement was mediated
by greater ability to generate momentary positive emotions, as well
as longer momentary persistence of positive emotions (Geschwind,
Peeters, Drukker, van Os, & Wichers, 2011). Another study reported
evidence that the effect of physical exercise on mood is also medi-
ated by changes in positive emotions (Wichers et al., 2012). The impor-
tance of ESM measures of positive emotions was further shown by
a study reporting that experienced PA, even over a single day, dis-
played a graded relationship with survival in elderly persons that was
not caused by baseline health status or other covariates (Steptoe, &
Wardle, 2011). Thus, positive emotions appear to play a crucial role in
facilitating the mobilization of resilience in the face of adversity, with
important consequences for coping and health (Tugade, Fredrickson, &
Barrett, 2004).
Given the importance of positive emotions, it has been proposed
that ESM is routinely used in clinical practice, not only to improve
diagnosis, empower patients, or enhance the effects of medication,
but also as a means to collect routine outcome data that, contrary to
symptom-based measures, yield insight in daily life adaptation (Barge-
Schaapveld et al., 1995) and changes in resilience in the form of posi-
tive emotions. One study found that of the different measures in ESM
that can be used as routine outcome measurement (ROM), changes in
positive emotions were the most sensitive to change, suggesting this
dimension represents a suitable measure for ROM in mental health
services (vanOs et al., 2014).
If ESM is used routinely in a specific mental health treatment set-
ting, it is possible to generate, using anonymized patient data, group-
based reference data of ESM patterns of emotions and behavior, as
described in this article, against which ESM trajectories pertaining to
individual patients can be interpreted, similar to the current analyses
(Delespaul, 2015). In the foreseeable future, machine learning tech-
niques may be used to help test hypotheses in single patients against a
largepopulationbaseof ESMreferencedata (Strauss, Peguero,&Hirst,
2013).
4 STARTING TO USE ESM IN CLINICAL
PRACTICE
To start using ESM in clinical practice, one may commence with 5-day
periods of ESM (eight beeps per day) at intake and after 6 weeks of
treatment. At both baseline (diagnosis) and after 6 weeks (treatment
response), clinician andpatient candiscuss the online feedback pattern
of emotions and reactivity, as shown in the figure for the PsyMate app
(Fig. 9). In addition, the clinician can encourage the patient to engage
in ESM over the entire 6-week period at a rate of, for example, 3–4
days of ESM per week. ESM can then be combined with a focus on
PA and a simple program aimed at enhancing frequency and persis-
tence of PA in daily life. In addition, in PsyMate, aspects of acceptance
and commitment andmindfulness exercises can be programmed in the
time series (Batink et al., 2016), thus providing an opportunity to com-
bine pharmacological or psychological treatmentwithmHealth ACTor
mindfulness-based exercises.
5 CONCLUSION
ESM is of low cost and high impact. Given widespread availability
of personal digital devices, intensive data collection based on ESM
is now sufficiently practicable to allow widespread use in psychiatry
and indeed medicine. ESM is empowering, providing co-ownership of
the process of diagnosis, treatment evaluation, and patient-reported
ROM. Blended care, based on a mix of face-to-face and ESM-based
outside-the-office treatment, has the potential to reduce costs and
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improve outcomes. ESM makes it possible to develop insight into
previous implicit patterns of thought, experience, and behavior, par-
ticularly if rapid personalized feedback is available. ESM-based self-
monitoring and feedback can enhance resilience by strengthening the
capacity to use natural rewards. Personalized trajectories of starting
or stopping medication can be more easily initiated and predicted if
sensitive feedback data are available in real time. In addition, person-
alized trajectories of symptoms, cognitive abilities, symptoms impact-
ing on other symptoms, the mental capacity to “bounce back” from
dynamic system disturbance and patterns of environmental reactiv-
ity yield uniquely personal data to support shared decisionmaking and
prognostication in clinical practice.
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